Structure Therapeutics Inc. ( GPCR) - Key Metrics
GPCR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.46 | -$1.65 | -$1.65 |
| 2026Q1 | $0 | -$1.05 | $0.21 | $0.19 |
| 2025Q4 | $0 | $0.56 | -$1.09 | -$1.11 |
| 2025Q3 | $0 | -$1.12 | -$0.87 | -$0.90 |
| 2025Q2 | $0 | -$1.06 | -$0.94 | -$0.95 |
GPCR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.13 |
| 2026Q1 | 0% | -11.48 |
| 2025Q4 | 0% | 28.98 |
| 2025Q3 | 0% | -6.31 |
| 2025Q2 | 0% | -4.80 |
GPCR
Price: $22.22
52 week price:
Earnings Per Share: -3.03 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.6 billion